Chevy Chase Trust’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,235
Closed -$298K 673
2021
Q3
$298K Sell
7,235
-9,153
-56% -$377K ﹤0.01% 630
2021
Q2
$928K Sell
16,388
-156,362
-91% -$8.85M ﹤0.01% 579
2021
Q1
$7.26M Sell
172,750
-1,022,658
-86% -$42.9M 0.03% 473
2020
Q4
$83.8M Sell
1,195,408
-93,350
-7% -$6.54M 0.3% 79
2020
Q3
$36.2M Buy
1,288,758
+165,274
+15% +$4.64M 0.14% 151
2020
Q2
$33.2M Buy
1,123,484
+93,368
+9% +$2.76M 0.13% 160
2020
Q1
$20.4M Buy
1,030,116
+59,159
+6% +$1.17M 0.1% 197
2019
Q4
$28.7M Buy
970,957
+34,101
+4% +$1.01M 0.11% 192
2019
Q3
$21.3M Buy
936,856
+76,971
+9% +$1.75M 0.09% 244
2019
Q2
$21.3M Buy
859,885
+158,145
+23% +$3.91M 0.09% 234
2019
Q1
$17.4M Buy
701,740
+181,921
+35% +$4.5M 0.07% 282
2018
Q4
$11.8M Buy
519,819
+17,680
+4% +$402K 0.06% 329
2018
Q3
$16M Buy
502,139
+53,991
+12% +$1.72M 0.07% 304
2018
Q2
$16.1M Buy
448,148
+54,850
+14% +$1.97M 0.07% 297
2018
Q1
$13M Buy
+393,298
New +$13M 0.06% 338